Extended liver resections for intrahepatic cholangiocarcinoma: Friend or foe?

Surgery (United States)

Volumn 157, Issue 4, 2015, Pages 656-665

  Bergeat, Damien ^a,b   Sulpice, Laurent ^a,b   Rayar, Michel ^a   Edeline, Julien ^b   Merdignac, Aude ^a,b   Meunier, Bernard ^a   Boucher, Eveline ^b   Boudjema, Karim ^a,b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD TRANSFUSION; CANCER PROGNOSIS; CANCER SIZE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL RISK; TREATMENT OUTCOME; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EVALUATION STUDY; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925368843     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.11.011     Document Type: Article

References (29)

1. S.D. Taylor-Robinson, M.B. Toledano, S. Arora, T.J. Keegan, S. Hargreaves, and A. Beck Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998 Gut 48 2001 816 820
2. T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 2001 1353 1357
3. T.M. Welzel, B.I. Graubard, H.B. El-Serag, Y.H. Shaib, A.W. Hsing, and J.A. Davila Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study Clin Gastroenterol Hepatol 5 2007 1221 1228
4. R. Wood, D.H. Brewster, L.A. Fraser, H. Brown, P.C. Hayes, and O.J. Garden Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland Eur J Cancer 39 2003 2087 2092
5. O. Farges, D. Fuks, Y.-P. Le Treut, D. Azoulay, A. Laurent, and P. Bachellier AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma Cancer 117 2011 2170 2177
6. D. Ribero, A. Pinna, and A. Guglielmi Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients Arch Surg 147 2012 1107 1113
7. L. Sulpice, M. Rayar, E. Boucher, M. Pracht, B. Meunier, and K. Boudjema Treatment of recurrent intrahepatic cholangiocarcinoma Br J Surg 99 2012 1711 1717
8. H. Lang, G.C. Sotiropoulos, N.R. Frühauf, M. Dömland, A. Paul, and E.-M. Kind Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period Ann Surg 241 2005 134 143
9. N. Yamanaka, E. Okamoto, T. Ando, T. Oriyama, J. Fujimoto, and K. Furukawa Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma Cancer 76 1995 2449 2456
10. H. Suzuki, S. Isaji, C. Pairojkul, and T. Uttaravichien Comparative clinicopathological study of resected intrahepatic cholangiocarcinoma in northeast Thailand and Japan J Hepatobiliary Pancreat Surg 7 2000 206 211
11. X.-X. Hu, and L.-N. Yan Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience Hepatogastroenterology 58 2011 1255 1259
12. S.M. Ali, C.J. Clark, V.M. Zaydfudim, F.G. Que, and D.M. Nagorney Role of major vascular resection in patients with intrahepatic cholangiocarcinoma Ann Surg Oncol 20 2013 2023 2028
13. D. Dindo, N. Demartines, and P.-A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
14. S. Balzan, J. Belghiti, O. Farges, S. Ogata, A. Sauvanet, and D. Delefosse The "50-50 Criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy Ann Surg 242 2005 824 829
15. O. Farges, D. Fuks, E. Boleslawski, Y.-P. Le Treut, D. Castaing, and A. Laurent Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group Ann Surg 254 2011 824 829
16. A. Guillaud, C. Pery, B. Campillo, A. Lourdais, S. Laurent, and K. Boudjema Incidence and predictive factors of clinically relevant bile leakage in the modern era of liver resections HPB (Oxford) 15 2013 224 229
17. G. Zimmitti, R.E. Roses, A. Andreou, J. Shindoh, S.A. Curley, and T.A. Aloia Greater complexity of liver surgery is not associated with an increased incidence of liver-related complications except for bile leak: an experience with 2,628 consecutive resections J Gastrointest Surg 17 2013 57 64 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855461/
18. M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, A. Togawa, and H. Yoshidome Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival Br J Surg 89 2002 1525 1531
19. J.-N. Vauthey, T.M. Pawlik, E.K. Abdalla, J.F. Arens, R.A. Nemr, and S.H. Wei Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 2004 722 732
20. W. Jing, G. Jin, X. Zhou, Y. Zhou, Y. Zhang, and C. Shao Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis Eur J Cancer Prev 21 2012 24 31
21. S.K. Reddy, O. Hyder, J.W. Marsh, G.C. Sotiropoulos, A. Paul, and S. Alexandrescu Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma J Gastrointest Surg 17 2013 748 755
22. F. Cauchy, S. Zalinski, S. Dokmak, D. Fuks, O. Farges, and L. Castera Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome Br J Surg 100 2013 113 121
23. S.Y. Cho, S.-J. Park, S.H. Kim, S.-S. Han, Y.-K. Kim, and K.-W. Lee Survival analysis of intrahepatic cholangiocarcinoma after resection Ann Surg Oncol 17 2010 1823 1830
24. E. Liapi, and J.-F.H. Geschwind Transcatheter and ablative therapeutic approaches for solid malignancies J Clin Oncol 25 2007 978 986
25. J.H. Kim, H.-K. Yoon, K.-B. Sung, G.-Y. Ko, D.I. Gwon, and J.H. Shin Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma Cancer 113 2008 1614 1622
26. J. Edeline, L. Lenoir, K. Boudjema, Y. Rolland, A. Boulic, and F. Le Du Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 20 2013 2518 2525
27. S. Mouli, K. Memon, T. Baker, A.B. Benson III, M.F. Mulcahy, and R. Gupta Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis J Vasc Interv Radiol 24 2013 1227 1234
28. C. Servajean, M. Gilabert, G. Piana, G. Monges, J.-R. Delpero, and I. Brenot One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization World J Gastroenterol 20 2014 5131 5134
29. L. Liu, Z. Wang, S. Jiang, B. Shao, J. Liu, and S. Zhang Perioperative allogeneic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis PLoS One 8 2013 e64261